Publications

Detailed Information

Low Ki-67 Proliferation Index Is an Indicator of Poor Prognosis in Gastric Cancer

DC Field Value Language
dc.contributor.authorLee, Hee Eun-
dc.contributor.authorKim, Min A.-
dc.contributor.authorLee, Byung Lan-
dc.contributor.authorKim, Woo Ho-
dc.date.accessioned2012-05-31T02:40:26Z-
dc.date.available2012-05-31T02:40:26Z-
dc.date.issued2010-09-01-
dc.identifier.citationJOURNAL OF SURGICAL ONCOLOGY; Vol.102 3; 201-206ko_KR
dc.identifier.issn0022-4790-
dc.identifier.urihttps://hdl.handle.net/10371/76658-
dc.description.abstractBackground and Objectives: We designed this study to assess the biologic significance of Ki-67 proliferation index (PI) in gastric cancer. Methods: Gastric cancer tissue from 245 patients were immunostained for Ki-67. Ki-67 PI was defined as the percentage of tumor cells positive for Ki-67. In addition, we have previously evaluated the expressions of nine epithelial mesenchymal transition (EMT)-related proteins. The relationship between Ki-67 PI and clinicopathologic parameters, patient survival, and EMT data were sought. Results: Low Ki-67 PI was correlated with poorly differentiated histology (P = 0.034), an advanced T stage (P < 0.001), and lymph node metastasis (P = 0.011). Also, the low PI group was found to have a significantly worse prognosis than the high PI group (P = 0.003, log-rank test). Multivariate analysis revealed that Ki-67 PI remained as an independent prognostic factor (hazard ratio (95% CI) = 0.670 (0.450-0.999)). Furthermore, greater expressional changes of EMT-related proteins were found to be significantly associated with low Ki-67 PI (P = 0.025). Conclusions: These findings suggest that Ki-67 PI is an effective tool for predicting survival in gastric cancer. In addition, we found that an invasive property presented as EMT-related protein expressional changes was inversely correlated with a proliferative activity in gastric cancer. J. Surg. Oncol. 2010;102:201-206. (C) 2010 Wiley-Liss, Inc.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-LISSko_KR
dc.subjectstomach neoplasmsko_KR
dc.subjectimmunohistochemistryko_KR
dc.subjecttissue array analysisko_KR
dc.subjectsurvival analysisko_KR
dc.titleLow Ki-67 Proliferation Index Is an Indicator of Poor Prognosis in Gastric Cancerko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이희은-
dc.contributor.AlternativeAuthor김민아-
dc.contributor.AlternativeAuthor이병란-
dc.contributor.AlternativeAuthor김우호-
dc.identifier.doi10.1002/jso.21583-
dc.citation.journaltitleJOURNAL OF SURGICAL ONCOLOGY-
dc.description.citedreferenceKim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x-
dc.description.citedreferenceHejna M, 2006, ONCOLOGIST, V11, P136-
dc.description.citedreferenceNovotny AR, 2006, ANN SURG, V243, P74, DOI 10.1097/01.sla.0000194088.81126.85-
dc.description.citedreferenceColozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352-
dc.description.citedreferenceGao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102-
dc.description.citedreferenceHartgrink HH, 2005, J SURG ONCOL, V90, P153, DOI 10.1002/jso.20222-
dc.description.citedreferenceROBBINS SL, 2005, ROBBINS COTRAN PATHO, P319-
dc.description.citedreferenceGarrity MM, 2004, J CLIN ONCOL, V22, P1572, DOI 10.1200/JCO.2004.10.042-
dc.description.citedreferencePan WS, 2003, J SURG ONCOL, V82, P104, DOI 10.1002/jso.10204-
dc.description.citedreferenceAllegra CJ, 2003, J CLIN ONCOL, V21, P241, DOI 10.1200/JCO.2003.05.044-
dc.description.citedreferenceEwton DZ, 2002, INT J CANCER, V98, P665, DOI 10.1002/ijc.10229-
dc.description.citedreferencePARKIN DM, 2002, CA CANC J CLIN, V55, P74-
dc.description.citedreferenceLiu XP, 2001, CANCER LETT, V170, P183-
dc.description.citedreferenceLee HS, 2001, CANCER, V92, P1427-
dc.description.citedreferenceGoishi H, 2000, ONCOL REP, V7, P713-
dc.description.citedreferenceScholzen T, 2000, J CELL PHYSIOL, V182, P311-
dc.description.citedreferenceFENOGLIOPREISER C, 2000, WHO CLASSIFICATION T, P37-
dc.description.citedreferenceBai XZ, 1999, INT J ONCOL, V14, P785-
dc.description.citedreferencePalmqvist R, 1999, BRIT J CANCER, V79, P577-
dc.description.citedreferenceKeshgegian AA, 1998, AM J CLIN PATHOL, V110, P443-
dc.description.citedreferencede Manzoni G, 1998, JPN J CLIN ONCOL, V28, P534-
dc.description.citedreferenceSetala L, 1998, J CANCER RES CLIN, V124, P497-
dc.description.citedreferenceKikuyama S, 1998, ONCOL REP, V5, P867-
dc.description.citedreferenceIacopetta B, 1998, CLIN CANCER RES, V4, P1597-
dc.description.citedreferenceBorre M, 1998, J UROLOGY, V159, P1609-
dc.description.citedreferenceSchipper DL, 1998, EUR J CANCER, V34, P781-
dc.description.citedreferenceUzoaru I, 1998, J SURG ONCOL, V67, P33-
dc.description.citedreferenceVictorzon M, 1997, ANTICANCER RES, V17, P2923-
dc.description.citedreferenceRamires M, 1997, J PATHOL, V182, P62-
dc.description.citedreferenceAaltomaa S, 1997, EUR UROL, V32, P410-
dc.description.citedreferenceKanai T, 1997, EUR SURG RES, V29, P35-
dc.description.citedreferenceMuller W, 1996, BRIT J CANCER, V74, P759-
dc.description.citedreferenceTakano Y, 1996, J CANCER RES CLIN, V122, P166-
dc.description.citedreferenceLEWIN KJ, 1996, ATLAS TUMOR PATHOL, P245-
dc.description.citedreferenceMCLOUGHLIN J, 1993, BRIT J UROL, V72, P92-
dc.description.citedreferenceCATTORETTI G, 1992, J PATHOL, V168, P357-
dc.description.citedreferenceWEIKEL W, 1991, BREAST CANCER RES TR, V18, P149-
dc.description.citedreferenceSADI MV, 1991, CANCER, V67, P3065-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share